Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Zou, Ruhai"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-10 z 10
    Tytuł:
    Comparison of the prognostic value of inflammation-based scores in early recurrent hepatocellular carcinoma after hepatectomy.
    Autorzy:
    Wang C; State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Guangzhou, China.; Department of Hepatobiliary Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, China.
    He W; State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Guangzhou, China.; Department of Hepatobiliary Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, China.
    Yuan Y; State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Guangzhou, China.; Department of Hepatobiliary Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, China.
    Zhang Y; State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Guangzhou, China.; Department of Hepatobiliary Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, China.
    Li K; State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Guangzhou, China.; Department of Hepatobiliary Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, China.
    Zou R; State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Guangzhou, China.; Department of Ultrasound, Sun Yat-Sen University Cancer Center, Guangzhou, China.
    Liao Y; State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Guangzhou, China.; Department of Hepatobiliary Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, China.
    Liu W; State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Guangzhou, China.; Department of Hepatobiliary Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, China.
    Yang Z; State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Guangzhou, China.; Department of Hepatobiliary Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, China.
    Zuo D; State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Guangzhou, China.
    Qiu J; State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Guangzhou, China.; Department of Hepatobiliary Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, China.
    Zheng Y; State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Guangzhou, China.; Department of Hepatobiliary Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, China.
    Li B; State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Guangzhou, China.; Department of Hepatobiliary Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, China.
    Yuan Y; State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Guangzhou, China.; Department of Hepatobiliary Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, China.
    Pokaż więcej
    Źródło:
    Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2020 Jan; Vol. 40 (1), pp. 229-239. Date of Electronic Publication: 2019 Nov 28.
    Typ publikacji:
    Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Hepatectomy*
    Carcinoma, Hepatocellular/*surgery
    Inflammation/*diagnosis
    Liver Neoplasms/*surgery
    Adult ; Carcinoma, Hepatocellular/mortality ; China/epidemiology ; Female ; Humans ; Inflammation/pathology ; Liver Neoplasms/mortality ; Lymphocytes/pathology ; Male ; Middle Aged ; Neoplasm Recurrence, Local/pathology ; Neutrophils/pathology ; Prognosis ; ROC Curve ; Retrospective Studies ; Survival Analysis
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Resection vs. ablation for alpha-fetoprotein positive hepatocellular carcinoma within the Milan criteria: a propensity score analysis.
    Autorzy:
    He W; State Key Laboratory of Oncology in South China and Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, China.; Department of Hepatobiliary Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, China.
    Li B; State Key Laboratory of Oncology in South China and Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, China.; Department of Hepatobiliary Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, China.
    Zheng Y; State Key Laboratory of Oncology in South China and Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, China.; Department of Hepatobiliary Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, China.
    Zou R; State Key Laboratory of Oncology in South China and Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, China.; Department of Ultrasound, Sun Yat-Sen University Cancer Center, Guangzhou, China.
    Shen J; State Key Laboratory of Oncology in South China and Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, China.; Department of Medical Imaging, Sun Yat-Sen University Cancer Center, Guangzhou, China.
    Cheng D; State Key Laboratory of Oncology in South China and Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, China.; Department of Hepatobiliary Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, China.
    Tao Q; State Key Laboratory of Oncology in South China and Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, China.; Department of Hepatobiliary Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, China.
    Liu W; State Key Laboratory of Oncology in South China and Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, China.; Department of Hepatobiliary Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, China.
    Li Q; State Key Laboratory of Oncology in South China and Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, China.; Department of Hepatobiliary Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, China.
    Chen G; Department of Surgery, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
    Yuan Y; State Key Laboratory of Oncology in South China and Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, China. .; Department of Hepatobiliary Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, China. .
    Pokaż więcej
    Źródło:
    Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2016 Nov; Vol. 36 (11), pp. 1677-1687. Date of Electronic Publication: 2016 Jun 03.
    Typ publikacji:
    Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Catheter Ablation*
    Hepatectomy*
    Carcinoma, Hepatocellular/*surgery
    Liver Neoplasms/*surgery
    Adult ; Aged ; Carcinoma, Hepatocellular/mortality ; China ; Female ; Humans ; Liver Neoplasms/mortality ; Logistic Models ; Male ; Middle Aged ; Propensity Score ; Retrospective Studies ; Survival Rate ; Treatment Outcome ; alpha-Fetoproteins/analysis
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    The role of clinically significant portal hypertension in hepatic resection for hepatocellular carcinoma patients: a propensity score matching analysis.
    Autorzy:
    He W; State Key Laboratory of Oncology in South China and Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, China. .; Department of Hepatobiliary Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, China. .
    Zeng Q; Department of Surgery, People's Hospital of Jiangxi Province, Nanchang, China. .
    Zheng Y; State Key Laboratory of Oncology in South China and Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, China. .; Department of Hepatobiliary Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, China. .
    Chen M; Department of Hepatobiliary Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, China. .
    Shen J; State Key Laboratory of Oncology in South China and Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, China. .; Department of Medical Imaging and Interventional Center, Sun Yat-Sen University Cancer Center, Guangzhou, China. .
    Qiu J; State Key Laboratory of Oncology in South China and Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, China. .; Department of Hepatobiliary Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, China. .
    Chen M; Department of Surgery, People's Hospital of Jiangxi Province, Nanchang, China. .
    Zou R; State Key Laboratory of Oncology in South China and Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, China. .; Department of Ultrasound, Sun Yat-Sen University Cancer Center, Guangzhou, China. .
    Liao Y; State Key Laboratory of Oncology in South China and Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, China. .; Department of Hepatobiliary Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, China. .
    Li Q; State Key Laboratory of Oncology in South China and Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, China. .; Department of Hepatobiliary Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, China. .
    Wu X; State Key Laboratory of Oncology in South China and Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, China. .; Department of Hepatobiliary Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, China. .
    Li B; State Key Laboratory of Oncology in South China and Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, China. .; Department of Hepatobiliary Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, China. .
    Yuan Y; State Key Laboratory of Oncology in South China and Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, China. .; Department of Hepatobiliary Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, China. .
    Pokaż więcej
    Źródło:
    BMC cancer [BMC Cancer] 2015 Apr 11; Vol. 15, pp. 263. Date of Electronic Publication: 2015 Apr 11.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Carcinoma, Hepatocellular/*surgery
    Hepatectomy/*adverse effects
    Hypertension, Portal/*surgery
    Liver Neoplasms/*surgery
    Adult ; Aged ; Carcinoma, Hepatocellular/complications ; Carcinoma, Hepatocellular/pathology ; Female ; Humans ; Hypertension, Portal/complications ; Hypertension, Portal/pathology ; Liver/pathology ; Liver/surgery ; Liver Neoplasms/complications ; Liver Neoplasms/pathology ; Male ; Middle Aged ; Postoperative Complications ; Prognosis ; Retrospective Studies
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Partial hepatectomy for liver metastases from nasopharyngeal carcinoma: a comparative study and review of the literature.
    Autorzy:
    Huang J
    Li Q
    Zheng Y
    Shen J
    Li B
    Zou R
    Wang J
    Yuan Y; Department of Hepatobiliary Oncology, Sun Yat-sen University Cancer Center, 651 Dongfeng Rd, E,, Guangzhou, Guangdong 510060, China. .
    Pokaż więcej
    Źródło:
    BMC cancer [BMC Cancer] 2014 Nov 07; Vol. 14, pp. 818. Date of Electronic Publication: 2014 Nov 07.
    Typ publikacji:
    Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Review
    MeSH Terms:
    Chemoembolization, Therapeutic*
    Hepatectomy*/methods
    Antineoplastic Combined Chemotherapy Protocols/*administration & dosage
    Liver Neoplasms/*therapy
    Nasopharyngeal Neoplasms/*pathology
    Adult ; Carboplatin/administration & dosage ; Carcinoma ; Chemotherapy, Adjuvant ; Disease Progression ; Disease-Free Survival ; Epirubicin/administration & dosage ; Ethiodized Oil/administration & dosage ; Female ; Follow-Up Studies ; Humans ; Liver Neoplasms/secondary ; Male ; Middle Aged ; Mitomycin/administration & dosage ; Nasopharyngeal Carcinoma ; Nasopharyngeal Neoplasms/secondary ; Nasopharyngeal Neoplasms/surgery ; Nasopharyngeal Neoplasms/therapy ; Radiotherapy, Adjuvant ; Retrospective Studies ; Survival Rate
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Repeat hepatectomy versus percutaneous ablation for recurrent hepatocellular carcinoma: emphasis on the impact of early or late recurrence.
    Autorzy:
    Wang, Chenwei
    Li, Kai
    Huang, Zhenkun
    Yuan, Yichuan
    He, Wei
    Zheng, Yun
    Zou, Ruhai
    Li, Binkui
    Yuan, Yunfei
    Qiu, Jiliang
    Pokaż więcej
    Temat:
    HEPATOCELLULAR carcinoma
    HEPATECTOMY
    PROPENSITY score matching
    OVERALL survival
    DISEASE relapse
    CANCER relapse
    Źródło:
    Journal of Cancer Research & Clinical Oncology; Nov2023, Vol. 149 Issue 16, p15113-15125, 13p
    Czasopismo naukowe
    Szczegóły
      Wyświetlanie 1-10 z 10

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies